Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

The local, intramyocardial injection of proteins into the infarcted heart is an attractive option to initiate cardiac regeneration after myocardial infarction (MI). Liraglutide, which was developed as a treatment for type 2 diabetes, has been implicated as one of the most promising protein candidate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Qi, Quan, Lu, Lei, Li, Haiqing, Yuan, Zhize, Chen, Gaoxian, Lin, Miao, Ruan, Zhengwen, Ye, Xiaofeng, Xiao, Zeyu, Zhao, Qiang
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511023/
https://ncbi.nlm.nih.gov/pubmed/28744119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S132064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars